Palliative care for delirium in patients in the last weeks of Life: The final frontier

Journal of Palliative Care

Volumn 30, Issue 4, 2014, Pages 259-264

  Hui, David ^a   De La Cruz, Maxine ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELIRIUM; HUMAN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; TERMINAL CARE; TERMINALLY ILL PATIENT;

DELIRIUM; HUMANS; PALLIATIVE CARE; TERMINAL CARE; TERMINALLY ILL;

EID: 84921730553     PISSN: 08258597     EISSN: 23695293     Source Type: Journal    
DOI: 10.1177/082585971403000403     Document Type: Article

References (50)

1. Lawlor PG, Gagnon B, Mancini I.L., et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000; 160(6): 786-794.
2. Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med 2004; 18(3): 184-194.
3. Hui D, Reddy A, Palla S., et al. Neuroleptic prescription pattern for delirium in patients with advanced cancer. J Palliat Care 2011; 27(2): 141-147.
4. Ely EW, Gautam S, Margolin R., et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001; 27(12): 1892-1900.
5. Lawlor PG, Bruera ED. Delirium in patients with advanced cancer. Hematol Oncol Clin North Am 2002; 16(3): 701-714.
6. Morita T, Akechi T, Ikenaga M., et al. Terminal delirium: recommendations from bereaved families' experiences. J Pain Symptom Manage 2007; 34(6): 579-589.
7. Fainsinger RL, Tapper M, Bruera E. A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care 1993; 9(3): 4-8.
8. Reddy SK, Nguyen N, El Osta B, et al. Opioids masquerading as delirium in a patient with cancer pain and obstructive sleep apnea. J Palliat Med 2008; 11(7): 1043-1045. doi:10.1089/jpm.2008.9864.
9. Morita T, Tei Y, Inoue S. Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients: prevalence and identification of research focus. J Pain Symptom Manage 2003; 26(3): 827-834.
10. Swigart SE, Kishi Y, Thurber S., et al. Misdiagnosed delirium in patient referrals to a university-based hospital psychiatry department. Psychosomatics 2008; 49(2): 104-108. doi:10.1176/appl.psy.492.104.
11. Wada T, Wada M, Wada M., et al. Characteristics, interventions, and outcomes of misdiagnosed delirium in cancer patients. Palliat Support Care 2010; 8(2): 125-131. doi:101017/S1478951509990861.
12. Burton CZ, Twamley EW, Lee L.C., et al. Undetected cognitive impairment and decision-making capacity in patients receiving hospice care. Am J Geriatr Psychiatry 2012; 20(4): 306-316. doi:10 1097/JGP.0b013e3182436987.
13. Maldonado JR. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry 2013; 21(12): 1190-1222. doi:10.1016/j.jagp.2013.09.005.
14. Inouye SK. Delirium in older persons. N Engl J Med 2006; 354(11): 1157-1165.
15. Adamis D. Statistical methods for analysing longitudinal data in delirium studies. Int Rev Psychiatry 2009; 21(1): 74-85. doi: 10.1080/09540260802675346
16. de Rooij SE, van Munster BC, Korevaar JC, et al. Cytokines and acute phase response in delirium. J Psychosom Res 2007; 62(5): 521-525.
17. van Munster BC, Korevaar JC, Zwinderman et al. Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc 2008; 56(9): 1704-1709. doi:10.1111/1.1532-5415.2008.01851.x.
18. Soiza RL, Sharma V, Ferguson K., et al. Neuroimaging studies of delirium: a systematic review. J Psychosom Res 2008; 65(3): 239-248. doi:10.1016/j.jpsychores.2008.05.021.
19. Liptzin B, Levkoff SE. An empirical study of delirium subtypes. Br J Psychiatry 1992; 161: 843-845.
20. Meagher DJ, Leonard M, Donnelly S., et al. A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis. J Psychosom Res 2011; 71(6): 395-403. doi:10.1016/j.jpsychores.2011.06.001.
21. Seitz DP, Gill SS, van Zyl LT. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry 2007; 68(1): 11-21.
22. Hui D, Dos Santos R, Chisholm G, et al. Clinical signs of impending death in cancer patients. Oncologist 2014; 19(6): 681-687. doi:10.1634/theoncologist2013-0457.
23. Hui D, Dos Santos R, Chisholm G, et al. Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings. Cancer; forthcoming 2014.
24. Hui D, Bush SH, Gallo L.E., et al. Neuroleptic dose in the management of delirium in patients with advanced cancer. J Pain Symptom Manage 2010; 39(2): 186-196. doi:10.1016/j.jpamsymman.2009.07.009.
25. Breitbart W, Strout D. Delirium in the terminally ill. Clin Geriatr Med 2000; 16(2): 357-372.
26. Breitbart W, Alici Y. Agitation and delirium at the end of life: "We couldn't manage him". JAMA 2008; 300(24): 2898-2910, E1. doi:10.1001/jama.2008.885.
27. Meagher DJ. Delirium: optimising management. BMJ 2001; 322(7279): 144-149.
28. National Collaborating Centre for Acute and Chronic Conditions. Delirium: diagnosis, prevention and management. London: National Institute for Health and Clinical Excellence; 2010. (Clinical guideline series; 103).
29. Candy B, Jackson KC, Jones L, et al. Drug therapy for delirium in terminally ill adult patients. Cochrane Database Syst Rev 2012; 11: CD004770. doi:10.1002/14651858.CD004770.pub2.
30. Breitbart W, Marotta R, Platt M.M., et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996; 153(2): 231-237.
31. Levy MH, Adolph MD, Back A, et al. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology. NCCN guidelines for supportive care: palliative care. Fort Washington (PA): NCCN; 2014.
32. Sweet L, Adamis D, Meagher D., et al. Ethical challenges and solutions regarding delirium studies in palliative care. J Pain Symptom Manage 2013; 48(2): 259-271. doi. 10.1016/j.jpam symman.2013.07.017.
33. Fan E, Shahid S, Kondreddi V.P., et al. Informed consent in the critically ill: a two-step approach incorporating delirium screening. Crit Care Med 2008; 36(1): 94-99.
34. Pandharipande PP, Pun BT, Herr D.L., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298(22): 2644-2653.
35. Riker RR, Shehabi Y, Bokesch P.M., et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009; 301(5): 489-499. doi:10.1001/jama.2009.56.
36. Trzepacz PT, Mittel D, Torres R., et al. Validation of the Delirium Rating Scale-revised-98: comparison with the Delirium Rating Scale and the Cognitive Test for Delirium. J Neuropsychiatry Clin Neurosci 2001; 13(2): 229-242.
37. Breitbart W, Rosenfeld B, Roth A., et al. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997; 13(3): 128-137.
38. Sessler CN, Gosnell MS, Grap M.J., et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002; 166(10): 1338-1344.
39. Ely EW, Truman B, Shintani A., et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003; 289(22): 2983-2991.
40. Morita T, Tsunoda J, Inoue S., et al. Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study. Palliat Med 2001; 15(3): 197-206.
41. Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002; 43(3): 183-194.
42. Bruera E, Bush SH, Willey J, et al. Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer 2009; 15(9): 2004-2012. doi. 10.1002/cncr.24215.
43. Hu H, Deng W, Yang H. A prospective random control study comparison of olanzapine and haloperidol in senile delirium. Chongqing Med J 2004; 8: 1234-1237.
44. Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004; 45(4): 297-301.
45. Kim SW, Yoo JA, Lee S.Y., et al. Risperidone versus olanzapine for the treatment of delirium. Hum Psychopharmacol 2010; 25(4): 298-302. doi:10.1002/hup.1117.
46. Tahir TA, Eeles E, Karapareddy V., et al. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 2010; 69(5): 485-490. doi:10.1016/J.jpsychores.2010.05.006
47. Graver S, Kumar V, Chakrabarti S. Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium. J Psychosom Res 2011; 71(4): 277-281. doi:10.1016/j.jpsychores.201101.019.
48. Skrobik YK, Bergeron N, Dumont M., et al. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004; 30(3): 444-449.
49. Reade MC, O'Sullivan K, Bates S, et al. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care 2009; 13(3): R75. doi:10.1186/CC7890.
50. Devlin JW, Roberts RJ, Fong J.J., et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38(2): 419-427. doi:10.1097/CCM.0b013e3181b9e302.